The Implantable Insulin Pump Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for implantable insulin pumps has seen substantial growth in recent years. The market, which was worth $3.54 billion in 2024, is expected to increase to $3.88 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.7%.
The Implantable Insulin Pump Global Market is expected to grow to $5.57 billion by 2029 with a compound annual growth rate (CAGR) of 9.5%.
Download Your Free Sample of the 2025 Implantable Insulin Pump Market Report and Uncover Key Trends Now!The key drivers in the implantable insulin pump market are:
• Expanding patient population with diabetes
• Rising adoption of personalized medicine
• Increasing focus on diabetes management efficiency
• Growing demand for non-invasive monitoring solutions
The implantable insulin pump market covered in this report is segmented –
1) By Type: Closed-Loop Insulin Pump, Open-Loop Insulin Pump
2) By Application: Type 1 Diabetes, Type 2 Diabetes
3) By End-User: Hospitals, Home-Care
Subsegments:
1) By Closed-Loop Insulin Pump: Fully Automated Closed-Loop Insulin Pump, Hybrid Closed-Loop Insulin Pump, Closed-Loop Insulin Pump with Continuous Glucose Monitoring (CGM), Closed-Loop Insulin Pump with Adaptive Insulin Delivery
2) By Open-Loop Insulin Pump: Manual Open-Loop Insulin Pump, Basal-Bolus Open-Loop Insulin Pump, Smart Open-Loop Insulin Pump, Patch-Style Open-Loop Insulin Pump
The key trends in the implantable insulin pump market are:
• The integration of AI and machine learning for improved insulin management is an emerging trend.
• Advancements in device miniaturization are shaping the future of the market.
• The market is increasingly influenced by the integration with mobile apps and cloud-based systems.
• The development of pumps with enhanced safety mechanisms and continued research and innovation is a growing trend.
Major players in the implantable insulin pump market are:
• Sanofi S.A.
• Abbott Laboratories
• Medtronic plc
• Dexcom Inc.
• Insulet Corporation
• Tandem Diabetes Care Inc.
• Ypsomed Holding AG
• Air Liquide Healthcare Ltd.
• Diabeloop SA
• Glooko Inc.
• ViCentra B.V.
• Bigfoot Biomedical Inc.
• Beta Bionics Inc.
• Senseonics Holdings Inc.
• INREDA DIABETIC B.V.
• TIDEPOOL Inc.
• Medtrum Technologies Inc.
• Sernova Corp.
• PhysioLogic Devices Inc.
• EOFLOW CO. LTD.
• CamDiab Ltd.
North America was the largest region in the implantable insulin pump market in 2024